期刊文献+

血清IFN-α、aCL和抗β2-GPⅠ抗体与系统性红斑狼疮患者血小板减少的相关性 被引量:1

Correlation between serum IFN-α,ACL,anti-β2-gpⅠantibodies and thrombocytopenia in patients with systemic lupus erythematosus
下载PDF
导出
摘要 目的探讨血清干扰素α(IFN-α)、抗心磷脂抗体(aCL)和抗β2糖蛋白Ⅰ(β2-GPI)抗体与系统性红斑狼疮(SLE)患者血小板减少的相关性。方法选取2018年1月~2019年6月在我院门诊及住院就诊的系统性红斑狼疮患者65例,其中血小板减少SLE患者20例(PLT<100×109/L,A组),无血小板减少组45例(101×109/L~370×109/L,B组),选取同期16例脾功能亢进(HS)患者为疾病对照组(C组),选取同期我院体检中心的健康体检者60人(D组)。酶联免疫吸附(ELISA)法检测四组血清IFN-α水平、抗aCL抗体、抗β2-GPI抗体和抗双链DNA抗体滴度,免疫比浊法检测CRP、补体C3和C4。结果A组SLE患者血清IFN-α水平、aCL和抗β2-GPI总抗体滴度均显著高于其余三组(均P<0.01),B组显著高于C和D组(P<0.05);A组抗dsDNA抗体滴度、CRP浓度和SLEDAI显著高于B组(均P<0.01),补体C3和C4显著低于B组(均P<0.01);血清IFN-α水平与aCL和抗β2-GP1总抗体滴度呈显著正相关(r=0.754,0.814,均P<0.01),IFN-α水平、aCL和抗β2-GPI总抗体滴度均与血小板呈显著负相关(r=0.651,0.717,0.688,均P<0.01)。结论SLE患者体内IFN-α水平、aCL和抗β2-GPⅠ总抗体滴度均与血小板呈负相关,提示IFN-α、aCL和抗β2-GPⅠ抗体与血小板减少有关。 Objective To explore the correlation between serum IFN-α,anti-cardiolipin antibody(ACL),anti-β2-glycoprotein1(β2-gpⅠ)antibody and thrombocytopenia in patients with systemic lupus erythematosus(SLE).Methods Sixty-five SLE patients diagnosed at our hospital from January 2018 to June 2019 were included in the study.The SLE group was further divided into two groups according to thrombocytopenia or not,thrombocytopenia(PLT<100×109/L,group A,20)and without thrombocytopenia(101×109/L-370×109/L,groupB,45).Sixteen patients with hypersplenism in the same period were selected as disease control group(Group C),and sixty healthy persons(Group D)were selected from the physical examination center of our hospital at serum IFN-αlevel,anti-ACL antibody,anti-β2gpⅠand anti-dsDNA antibody titer were detected by ELISA,CRP,complement C3 and C4 were detected by immunoturbidimetry.Results Serum IFN-αlevel,anti-ACL antibody and anti-β2-gpⅠantibody titers in group A were significantly higher than those in the other three groups(P<0.01),and those indexes in group B were significantly higher than groups C and D(P<0.05).The anti-dsDNA antibody titer,CRP concentration and SLEDAI in group A were significantly higher than group B(all P<0.01),and complement C3 and C4 were significantly lower than group B(all P<0.01).Serum IFN-αlevels were significantly positively correlated with ACL and anti-β2gpⅠtotal antibody titers(r=0.754,0.814,all P<0.01).IFN-αlevel,ACL and anti-β2gpⅠtotal antibody titers were significantly negatively correlated with platelets(r=0.651,0.717,0.688,all P<0.01).Conclusion IFN-αlevel,ACL and anti-β2gpⅠtotal antibody titer were negatively correlated with platelet,sugested that IFN-α,ACL and anti-β2gpⅠantibodies are associated with thrombocytopenia.
作者 陈华良 廖永强 任妹 朱静茹 CHEN Hualiang;LIAO Yongqiang;REN mei;ZHU Jingru(Department of Clinical laboratory,Pingxiang People’s Hospital,Pingxiang 337000,Jiangxi,China;Department of Rheumatology, Pingxiang People’s Hospital, Pingxiang 337000, Jiangxi, China)
出处 《西部医学》 2021年第10期1549-1552,1556,共5页 Medical Journal of West China
基金 江西省卫生健康委科技计划项目(20204380)。
关键词 系统性红斑狼疮 干扰素Α 抗心磷脂抗体 抗β2糖蛋白Ⅰ抗体 血小板减少 Systemic lupus erythematosus IFN-α Anticardiolipin antibody Anti-β
  • 相关文献

参考文献7

二级参考文献31

  • 1Romay-Penabad Z,Montiel-Manzano MG,Shilagard T,et al.Annexin A2 is involved in antiphospholipid antibodymediated pathogenic effects in vitro and in vivo[J].Blood,2009,114:3074-3083.
  • 2Ramesh S,Morrell CN,Tarango C,et ai Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombos is in mice by antagonizi ng eNOS via b2GPI and apoER2[J].J Clin Invest,2011,121:120-131.
  • 3Romay-Penabad Z,Aguilar-Valenzuela R,Urbanus RT,et al.Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome[J].Blood,2011,117:1408-1414.
  • 4Arad A,Proulle V,Furie RA,et al.b2-glycoprotein-1autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model[J].Blood,2011,117:3453-3459.
  • 5Andreoli L,Fredi M,Nalli C,et al.Clinical significance of IgA anti-cardiolipin and IgA anti-β2glycoprotein I antibodies[J].Curr Rheumatol Rep,2013,15:343.
  • 6Kumar S,Papalardo E,Sunkureddi P,et al.Isolated elevation of IgA anti-beta2glyeoprotein I antibodies with manifestations of antiphospholipid syndrome:a case series of five patients[J].Lupus,2009,18:1011-1014.
  • 7Danowski A,Kickler T,Petri M.Anti-B2-glycoprotein I:prevalence,clinical correlations,and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus[J].J Rheumatol,2006,33:1775-1779.
  • 8Lakos G,Kiss E,Regeczy P,et al.Isotype distribution and clinical relevance of anti-β2-glycoprotein I antibodies:importance of IgA isotype[J].Clin Exp Immunol,1999,117:574-579.
  • 9Lee S,Cho M,Joo Y,et al.Isotypes of anti-β2-glycoprotein I antibodies:association with thrombosis in patients with systemic lupus erythematosus[J].J Rheumatol,2001,28:520-524.
  • 10Mehrani T,Petri M.Association of IgA Anti-beta2glycoprotein I with clinical and laboratory manifestations of systemic lupus erythematosus[J].Rheumatol,2011,38-64-68.

共引文献65

同被引文献28

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部